Back
AC Immune SA Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
37
ACIU
AC Immune SA
Last Price:
2.33
Seasonality Move:
4.61%
Sell
34
NLSP
NLS Pharmaceutics
Last Price:
0.14
Seasonality Move:
-32.49%
Sell
37
AC Immune SA (ACIU)
is a Sell
Is AC Immune SA a Buy, Sell or Hold?
- The current AC Immune SA [ACIU] share price is $2.31. The Score for ACIU is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ACIU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $0.14. The Score for NLSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACIU Stock Price Chart
What is AC Immune SA's stock price today?
-
The AC Immune SA share price today is $2.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACIU is experiencing selling pressure, which indicates risk of future bearish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $0.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACIU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 33.6 | Sell |
| Chaikin Money Flow: | -95832 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.31 - 2.63) | Sell |
| Bollinger Bands (100): | (2.58 - 4.1) | Sell |
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 38.04 | Sell |
| Chaikin Money Flow: | 12281 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.13 - 0.15) | Sell |
| Bollinger Bands (100): | (0.18 - 0.48) | Sell |
ACIU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Sell |
| 20-day SMA: | 2.4 | Sell |
| 50-day SMA: | 2.88 | Sell |
| 200-day SMA: | 3.19 | Sell |
| 8-day EMA: | 2.37 | Sell |
| 20-day EMA: | 2.46 | Sell |
| 50-day EMA: | 2.76 | Sell |
| 200-day EMA: | 3.06 | Sell |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.14 | Buy |
| 20-day SMA: | 0.14 | Buy |
| 50-day SMA: | 0.2 | Sell |
| 200-day SMA: | 0.53 | Sell |
| 8-day EMA: | 0.14 | Buy |
| 20-day EMA: | 0.14 | Sell |
| 50-day EMA: | 0.2 | Sell |
| 200-day EMA: | 0.49 | Sell |
AC Immune SA Earnings Growth & ACIU Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.65 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AC Immune SA Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NLS Pharmaceutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||